云南高校图书馆联盟文献共享服务平台- PROSTATE

PROSTATE_CANCER: 作品数：1256被引量：2510H指数：19; 导出分析报告; 相关作者：王增军邱实黄鹰段秀枝魏强更多>>; 相关机构：浙江大学医学院附属第二医院江苏省人民医院复旦大学上海交通大学医学院附属第九人民医院更多>>; 相关期刊：更多>>; 相关基金：国家自然科学基金国家重点基础研究发展计划广东省自然科学基金北京市自然科学基金更多>>

Integrated analysis of single-cell and bulk transcriptomes uncovers clinically relevant molecular subtypes in human prostate cancer: 《Chinese Journal of Cancer Research》2025年第1期90-114,共25页Tao Ding Lina He Guowen Lin Lei Xu Yanjun Zhu Xinan Wang Xuefei Liu Jianming Guo Fanghong Lei Zhixiang Zuo Jianghua Zheng; supported by Shanghai Science and Technology Commission,China(No.21S11902100);Shanghai Municipal Health Commission Scientific Research Project(No.202140308);Clinical Research Project of Tongji Hospital of Tongji University[No.ITJ(ZD)2209];Shanghai Tongji Hospital National Natural Science Foundation Cultivation Project(No.GJPY2216);Shanghai Medical Innovation Research Special Foundation(No.23Y11908800);CSCO-Haosen Oncology Research Fund(No.Y-HS202301-0096).; Objective:Prostate cancer(PCa)is a complex disease characterized by diverse cellular ecosystems within the tumor microenvironment(TME)and high tumor heterogeneity,which challenges clinically stratified management and ...; 关键词：Single-cell RNA sequencing prostate cancer lineage plasticity tumor heterogeneity molecular classification

Focal ablation therapy presents promising results for selectively localized prostate cancer patients: 《Chinese Journal of Cancer Research》2023年第4期424-430,共7页Dechao Feng Dengxiong Li Yuhan Xiao Ruicheng Wu Jie Wang Chi Zhang; supported by the Luzhou City Science and Technology Bureau (No.2020LZXNYDJ10 and 2020LZXNYDJ14);Cooperation Project between the Second People’s Hospital of Deyang and Southwest Medical University (No.2022DYEXNYD002)。; Due to its lower risk of consequences when compared to a radical approach, focal treatment is a viable and minimally invasive option for treating specific localized prostate cancer. Although several recent good nonran...; 关键词：Prostate cancer focal ultrasound ablation focal laser ablation targeted microwave ablation

Comments on National guidelines for diagnosis and treatment of prostate cancer 2022 in China (English version)被引量：3: 《Chinese Journal of Cancer Research》2022年第5期456-457,共2页Yong Yang; National guidelines for diagnosis and treatment of prostate cancer 2022 in China (English version)(1) was organized by the National Health Commission of the People’s Republic of China, led by the Cancer Hospital of t...; 关键词：DIAGNOSIS CANCER TREATMENT

National guidelines for diagnosis and treatment of prostate cancer 2022 in China(English version)被引量：2: 《Chinese Journal of Cancer Research》2022年第3期270-288,共19页无 Yong Yang; Contents 1.Overview 2.Etiology 2.1 Age and genetic factors 2.2 Exogenous factors 3.Pathological classification and grading system 3.1 Pathological grading and grouping of prostate cancer 3.2 Staging of prostate cancer...; 关键词：DIAGNOSIS CANCER TREATMENT

Chinese guidelines for diagnosis and treatment of prostate cancer 2018 (English version)被引量：12: 《Chinese Journal of Cancer Research》2019年第1期67-83,共17页National Health Commission of the People’s Republic of China; Contents1. Overview2. Risk factors of prostate cancer2.1 Age and genetic factors2.2 Exogenous factors3. Pathological classification and grading system4. Diagnostic evaluation4.1 Monitoring and screening for population...; 关键词：ENGLISH VERSION CHINESE GUIDELINES TREATMENT

PCA3 and TMPRSS2-ERG gene fusions as diagnostic biomarkers for prostate cancer被引量：13: 《Chinese Journal of Cancer Research》2016年第1期65-71,共7页Zheng Yang Lu Yu Zhe Wang; supported by the following grants: National Natural Science Foundation of China No. 31571413, 31201037 (to Dr. Yu) and No. 81570180, 81072103 (to Dr. Wang) from the National Natural Science Foundation of China; The incidence of prostate cancer （PCa） is rising steadily among males in many countries. Serum prostate-specific antigen （PSA） is widely applied to clinical diagnosis and screening of PCa. However, the so-called g...; 关键词：Prostate prostate cancer antigen 3 （PCA3） TMPRSS2-ERG gene fusion prostate cancer （PCa） biomarker

Molecular aspects of prostate cancer with neuroendocrine differentiation被引量：2: 《Chinese Journal of Cancer Research》2016年第1期122-129,共8页Qi Li Connie S. Zhang Yifen Zhang; supported by the National Natural Science Foundation of China (81502244); Neuroendocrine differentiation （NED）, which is not uncommon in prostate cancer, is increases in prostate cancer after androgen-deprivation therapy （ADT） and generally appears in castration- resistant prostate canc...; 关键词：Prostate cancer neuroendocrine differentiation （NED） molecular components

Function of PCA3 in prostate tissue and clinical research progress on developing a PCA3 score被引量：5: 《Chinese Journal of Cancer Research》2014年第4期493-500,共8页Yue Wang Xiao-Jun Liu Xu-Dong Yao; supported by grants from the National Natural Science Foundation of China (81272836); Prostate cancer gene 3 （PCA3, also known as DD3） is a new biomarker that could improve the accuracy of prostate cancer diagnosis. It is a great biomarker with fairly high specificity and sensitivity. The incidence o...; 关键词：Prostate cancer gene 3 （PCA3） lncRNA prostate cancer （PCa） prostate-specific antigen （PSA）

Highlights in focus issue on prostate cancer: 《Chinese Journal of Cancer Research》2013年第6期784-785,共2页Eunice X.Xu; In September 2013, the Translational Andrology and Urology （FAU） launched a focus issue on“Prostate Cancer”, which was guest-edited by Dr. Jer-Tsong Hsieh and Dr. Ganesh Raj from University of Texas Southwestern M...; 关键词：USA Highlights in focus issue on prostate cancer TAU

Impact of comorbidity in elderly prostate cancer patients treated with brachytherapy: 《Chinese Journal of Cancer Research》2013年第3期274-280,共7页Costanza Chiumento Alba Fiorentino Mariella Cozzolino Rocchina Caivano Stefania Clemente Piernicola Pedicini Vincenzo Fusco; Objective： To analyze the correlations among comorbidity and overall survival （OS）, biochemical progression-free survival （b-PFS） and toxicity in elderly patients with localized prostate cancer treated with 125I ...; 关键词：Prostate cancer braehytherapy ELDERLY COMORBIDITY TOXICITY overall survival biochemical control

PROSTATE_CANCER